16684 Federal Register / Vol. 80, No. 60 / Monday, March 30, 2015 / Notices 

Program for Education and Training in 

Pain Care. 

The members of the ACICBL will 

resume their discussion of the 

legislatively mandated 15th Annual 

Report to the Secretary of Health and 

Human Services and Congress. The 

Committee members will continue to 

review, discuss, and make 

recommendations for programs under 

title VII, part D. The members will hear 

presentations on allied health, podiatry, 

chiropractic, pain care management, the 

budget process, primary care workforce 

reports, healthcare practice redesign, 

interprofessional accreditation 

standards, and performance 

measurement. 

Agenda: Healthcare practice redesign 

initiatives, such as the Patient-Centered 

Medical Home Model or the Planned 

Care Model, are emerging approaches to 

improve the quality of primary health 

care delivery. These models are 

comprehensive, multifaceted, and seek 

to provide high-quality care and 

continuity while involving patients, 

communities, health care teams, and 

policy makers. The members of the 

ACICBL will review (a) current issues 

related to healthcare practice redesign, 

(b) the implications of practice redesign 

on health professions education in 

relation to title VII, part D programs, 

and (c) accreditation standards for the 

disciplines that have incorporated 

interprofessional education into their 

accreditation standards and the effect 

this has had on practice. Committee 

discussion questions include: 

• How will changing the scope of 

practice of health professionals affect 

title VII, part D programming? 

• What statutory changes are needed 

to align with healthcare practice 

redesign? 

• What measures are needed for title 

VII, part D programs to have an impact 

on outcomes and quality? 

The official agenda will be available 

2 days prior to the meeting on the HRSA 

Web site at: http://www.hrsa.gov/

advisorycommittees/bhpradvisory/

acicbl/index.html. Agenda items are 

subject to change as priorities dictate. 

Public Comment: Requests to make 

oral comments or provide written 

comments to the ACICBL should be sent 

to Dr. Joan Weiss, Designated Federal 

Official, using the address and phone 

number below. Individuals who plan to 

participate on the conference call or 

webinar should notify Dr. Weiss at least 

3 days prior to the meeting, using the 

address and phone number below. 

Members of the public will have the 

opportunity to provide comments. 

Interested parties should refer to the 

meeting subject as the HRSA Advisory 

Committee on Interdisciplinary, 

Community-Based Linkages. 

The conference call-in number is 877– 

960–9066. The passcode is: 5919914. 

The webinar link is: https://

hrsa.connectsolutions.com/

acicblapril22_23/. 

FOR FURTHER INFORMATION CONTACT: 

Anyone requesting information 

regarding the ACICBL should contact 

Dr. Joan Weiss, Designated Federal 

Official within the Bureau of Health 

Workforce, Health Resources and 

Services Administration, in one of three 

ways: (1) Send a request to the following 

address: Dr. Joan Weiss, Designated 

Federal Official, Bureau of Health 

Workforce, Health Resources and 

Services Administration, Parklawn 

Building, Room 12C–05, 5600 Fishers 

Lane, Rockville, Maryland 20857; (2) 

call (301) 443–0430; or (3) send an email 

to jweiss@hrsa.gov. 

Jackie Painter, 

Director, Division of the Executive Secretariat. 

[FR Doc. 2015–07154 Filed 3–27–15; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Establishment of the Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria and 

Solicitation of Nominations for 

Appointment to the Council 

Membership 

AGENCY: Office of the Secretary, 

Department of Health and Human 

Services. 

ACTION: Notice. 

Authority: Executive Order 13676, 

dated September 18, 2014, authorizes 

establishment of the Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria (Advisory 

Council). The Advisory Council will be 

governed by provisions of the Federal 

Advisory Committee Act, Public Law 

92–463, as amended (5 U.S.C. App.), 

which sets forth standards for the 

formation and use of federal advisory 

committees. 

SUMMARY: The U.S. Department of 

Health and Human Services (HHS) 

announces establishment of the 

Advisory Council. The Advisory 

Council will provide advice, 

information, and recommendations to 

the Secretary regarding programs and 

policies intended to support and 

evaluate the implementation of 

Executive Order 13676, including the 

National Strategy for Combating 

Antibiotic-Resistant Bacteria (Strategy) 

and the National Action Plan for 

Combating Antibiotic-Resistant Bacteria 

(Action Plan). 

This notice also will serve to 

announce that HHS is seeking 

nominations of individuals who are 

interested in being considered for 

appointment to the Advisory Council. 

Resumes or curricula vitae from 

qualified individuals who wish to be 

considered for appointment as a 

member of the Advisory Council are 

currently being accepted. 

DATES: Nominations must be received 

no later than close business April 29, 

2015. 

ADDRESSES: All nominations should be 

sent to: Bruce Gellin, M.D., M.P.H., 

Deputy Assistant Secretary for Health; 

Office of the Assistant Secretary for 

Health; Department of Health and 

Human Services; 200 Independence 

Avenue SW., Room 715H; Washington, 

DC 20201. Nomination materials, 

including attachments, also may be 

submitted electronically to CARB@

hhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

Bruce Gellin, M.D., M.P.H., Deputy 

Assistant Secretary for Health; Office of 

the Assistant Secretary for Health; 

Department of Health and Human 

Services; Telephone: (202) 260–6638; 

Fax: (202) 690–4631; Email address: 

CARB@hhs.gov. The Advisory Council 

charter may be accessed online at 

http://www.hhs.gov/ash/carb. The 

charter includes detailed information 

about the Advisory Council’s purpose, 

function, and structure. 

SUPPLEMENTARY INFORMATION: The rise of 

antibiotic-resistant bacteria represents a 

serious threat to public health and the 

economy. Detecting, preventing, and 

controlling antibiotic resistance requires 

a strategic, coordinated, and sustained 

effort. The federal government will work 

domestically and internationally to 

detect, prevent, and control illness and 

death related to antibiotic-resistant 

infections by implementing measures 

that reduce the emergence and spread of 

antibiotic-resistant bacteria and help 

ensure the continued availability of 

effective therapeutics for the treatment 

of bacterial infections. 

Under Executive Order 13676, the 

Secretary of Health and Human Services 

(the Secretary) is directed to establish 

the Advisory Council in consultation 

with the Secretaries of Defense and 

Agriculture. The Advisory Council will 

provide advice and recommendations to 

the Secretary regarding programs and 

policies to support and evaluate the 

implementation of Executive Order 

13676, including the National Strategy 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 80, No. 60 / Monday, March 30, 2015 / Notices 16685 

for Combating Antibiotic-Resistant 

Bacteria (Strategy) and the National 

Action Plan for Combating AntibioticResistant Bacteria (Action Plan). On 

March 24, 2015, the Secretary approved 

for the Advisory Council to be 

established. The charter for the 

Advisory Council was filed with the 

appropriate Congressional committees 

and the Library of Congress on the same 

date. The Advisory Council has been 

established as a non-discretionary 

federal advisory committee. 

Objectives and Scope of Activities. 

The Advisory Council will provide 

advice, information, and 

recommendations to the Secretary 

regarding programs and policies 

intended to support and evaluate the 

implementation of Executive Order 

13676, including the Strategy and 

Action Plan. The Advisory Council will 

function solely for advisory purposes. 

Membership and Designation. The 

Advisory Council will consist of not 

more than 30 members, including the 

voting and non-voting members and 

Chair and Vice Chair. The members will 

be appointed or designated by the 

Secretary, who will designate the Chair 

and Vice Chair from among the voting 

members of the Advisory Council. 

Voting Members. There will be public 

voting members selected from 

individuals who are engaged in research 

on, or implementation of, interventions 

regarding efforts to preserve the 

effectiveness of antibiotics by 

optimizing their use; advance research 

to develop improved methods for 

combating antibiotic resistance and 

conducting antibiotic stewardship; 

strengthen surveillance of antibioticresistant bacterial infections; prevent 

the transmission of antibiotic-resistant 

bacterial infections; advance the 

development of rapid point-of-care and 

agricultural diagnostics; further research 

on new treatments for bacterial 

infections; develop alternatives to 

antibiotics for agricultural purposes; 

maximize the dissemination of up-todate information on the appropriate and 

proper use of antibiotics to the general 

public and human and animal 

healthcare providers; and improve 

international coordination of efforts to 

combat antibiotic resistance. 

The public voting members will 

represent balanced points of view from 

human biomedical, public health, and 

agricultural fields to include 

surveillance of antibiotic-resistant 

infections, prevention and/or 

interruptions of the spread of antibioticresistant threats, or development of 

rapid diagnostics and novel treatments. 

The public voting members may be 

physicians, veterinarians, 

epidemiologists, microbiologists, or 

other health care professionals (e.g., 

nurses, pharmacists, others); individuals 

who have expertise and experience as 

consumer or patient advocates 

concerned with antibiotic resistance, or 

in the fields of agriculture and 

pharmaceuticals; and they also may be 

from State or local health agencies or 

public health organizations. All public 

voting members will be classified as 

special Government employees (SGEs). 

Ex-officio Members (non-voting). The 

Advisory Council will include members 

selected to represent various federal 

agencies, including HHS, DoD, and 

USDA, that are involved in the 

development, testing, licensing, 

production, procurement, distribution, 

and/or use of antibiotics and/or 

antibiotic research. The federal exofficio members shall possess the 

knowledge, skills, experience, and 

expertise necessary to generate informed 

and intelligent recommendations with 

respect to the issues mandated by 

Executive Order 13676. Federal agencies 

will be invited to participate as nonvoting ex-officio members of the 

Advisory Council, as it is deemed 

necessary by the Secretary, in 

consultation with the Secretaries of 

Defense and Agriculture, to accomplish 

the mission the Advisory Council. 

Liaison Representatives (non-voting). 

The Advisory Council structure also 

may include non-voting liaison 

representatives from organizations and/ 

or interest groups that have involvement 

in the development, testing, licensing, 

production, procurement, distribution, 

and/or use of antibiotics and/or 

antibiotic research. Organizations will 

be invited to participate as non-voting 

liaison representatives as it is deemed 

necessary by the Secretary or designee 

to accomplish the established mission of 

the Advisory Council. 

The public voting and non-voting 

liaison representative members will be 

appointed to serve for overlapping terms 

of up to four years. The Chair and Vice 

Chair will be appointed to serve for 

three years, unless otherwise specified. 

The public voting members are 

authorized to receive per diem and 

reimbursement for travel expenses when 

attending meetings of the Advisory 

Council, as authorized by Section 5703, 

Title 5 U.S.C., as amended for persons 

employed intermittently in Government 

service. Individuals who are appointed 

to serve as non-voting liaison 

representative members also may be 

allowed to receive per diem and 

reimbursement for any applicable 

expenses for travel that is performed to 

attend meetings of the Advisory Council 

in accordance with Federal travel 

regulations. 

Estimated Number and Frequency of 

Meetings. The Advisory Council will 

meet, at a minimum, two times per 

fiscal year depending on the availability 

of funds. Meetings will be open to the 

public, except as determined otherwise 

by the Secretary or other official to 

whom the authority has been delegated 

in accordance with guidelines under 

Government in the Sunshine Act, 5 

U.S.C. 552b(c). 

Nominations: Nominations, including 

self-nominations, of individuals who 

have the specified expertise and 

knowledge will be considered for 

appointment as public voting and/or 

non-voting members of the Advisory 

Council. A nomination should include, 

at a minimum, the following for each 

nominee: (1) A letter of nomination that 

clearly states the name and affiliation of 

the nominee, the basis for the 

nomination (i.e., the desired member 

category and specific attributes which 

qualify the nominee to be considered for 

appointment as a public voting and/or 

non-voting member of the Advisory 

Council), and a statement from the 

nominee (including designated 

representatives of organizations and/or 

interest groups) that indicates that the 

individual is willing to serve as a 

member of the Advisory Council, if 

selected; (2) the nominator’s name, 

address, and daytime telephone 

number, and the address, telephone 

number, and email address of the 

individual being nominated; and (3) a 

current copy of the nominee’s 

curriculum vitae or resume, which 

should be limited to no more than 10 

pages. 

Every effort will be made to ensure 

that the Advisory Council is a diverse 

group of individuals with representation 

from various geographic locations, racial 

and ethnic minorities, all genders, and 

persons living with disabilities. 

Individuals being considered for 

appointment as public voting members 

will be required to complete and submit 

a report of their financial holdings. An 

ethics review must be conducted to 

ensure that individuals appointed as 

public voting members of the Advisory 

Council are not involved in any activity 

that may pose a potential conflict of 

interest for the official duties that are to 

be performed. This is a federal ethics 

requirement that must be satisfied upon 

entering the position and annually 

throughout the established term of 

appointment on the Advisory Council. 

mstockstill on DSK4VPTVN1PROD with NOTICES

16686 Federal Register / Vol. 80, No. 60 / Monday, March 30, 2015 / Notices 

Dated: March 24, 2015. 

Sylvia M. Burwell, 

Secretary of Health and Human Services. 

[FR Doc. 2015–07235 Filed 3–27–15; 8:45 am] 

BILLING CODE 4150–28–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers: CMS–29, CMS–10221 

and CMS–R–263] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by April 29, 2015. 

ADDRESSES: When commenting on the 

proposed information collections, 

please reference the document identifier 

or OMB control number. To be assured 

consideration, comments and 

recommendations must be received by 

the OMB desk officer via one of the 

following transmissions: OMB, Office of 

Information and Regulatory Affairs, 

Attention: CMS Desk Officer, Fax 

Number: (202) 395–5806 OR Email: 

OIRA_submission@omb.eop.gov. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ Web site address at 

http://www.cms.hhs.gov/Paperwork

ReductionActof1995. 

2. Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov. 

3. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

Reports Clearance Office at (410) 786– 

1326. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Verification of 

Clinic Data—Rural Health Clinic Form 

and Supporting Regulations; Use: The 

form is utilized as an application to be 

completed by suppliers of Rural Health 

Clinic (RHC) services requesting 

participation in the Medicare program. 

This form initiates the process of 

obtaining a decision as to whether the 

conditions for certification are met as a 

supplier of RHC services. It also 

promotes data reduction or introduction 

to and retrieval from the Automated 

Survey Process Environment (ASPEN) 

and related survey and certification 

databases by the CMS Regional Offices. 

Should any question arise regarding the 

structure of the organization, this 

information is readily available. Form 

Number: CMS–29 (OMB control number 

0938–0074); Frequency: Occasionally 

(initially and then every six years); 

Affected Public: Private Sector (Business 

or other for-profit and Not-for-profit 

institutions); Number of Respondents: 

900; Total Annual Responses: 900; Total 

Annual Hours: 150. (For policy 

questions regarding this collection 

contact Shonte ́ Carter at 410–786–3532.) 

2. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Site 

Investigation for Independent 

Diagnostic Testing Facilities (IDTFs); 

Use: We enroll Independent Diagnostic 

Testing Facilities (IDTFs) into the 

Medicare program via a uniform 

application, the CMS 855B. 

Implementation of enhanced procedures 

for verifying the enrollment information 

has improved the enrollment process as 

well as identified and prevented 

fraudulent IDTFs from entering the 

Medicare program. As part of this 

process, verification of compliance with 

IDTF performance standards is 

necessary. The primary function of the 

site investigation form for IDTFs is to 

provide a standardized, uniform tool to 

gather information from an IDTF that 

tells us whether it meets certain 

standards to be a IDTF (as found in 42 

CFR 410.33(g)) and where it practices or 

renders its services. The site 

investigation form has been used in the 

past to aid in verifying compliance with 

the required performance standards 

found in 42 CFR 410.33(g). No revisions 

have been made to this form since the 

last submission for OMB approval. Form 

Number: CMS–10221 (OMB Control 

Number: 0938–1029); Frequency: 

Occasionally; Affected Public: Private 

Sector (Business or other for-profits and 

Not-for-profit institutions); Number of 

Respondents: 900; Total Annual 

Responses: 900; Total Annual Hours: 

1,800. (For policy questions regarding 

this collection contact Kim McPhillips 

at 410–786–5374). 

3. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Site 

Investigation for Suppliers of Durable 

Medical Equipment, Prosthetics, 

Orthotics and Supplies (DMEPOS); Use: 

We enroll suppliers of durable medical 

equipment, prosthetics, orthotics, and 

supplies (DMEPOS) into the Medicare 

program via a uniform application, the 

CMS 855S. Implementation of enhanced 

procedures for verifying the enrollment 

information has improved the 

enrollment process as well as identified 

and prevented fraudulent DMEPOS 

suppliers from entering the Medicare 

program. As part of this process, 

verification of compliance with supplier 

standards is necessary. The primary 

function of the site investigation form is 

to provide a standardized, uniform tool 

to gather information from a DMEPOS 

mstockstill on DSK4VPTVN1PROD with NOTICES